Literature DB >> 22751423

Kallmann syndrome in a female adolescent: a new mutation in the FGFR1 gene.

Ana Novo1, Isabel Couto Guerra, Felisbela Rocha, Susana Gama-de-Sousa, Teresa Borges, Rita Cerqueira, Purificação Tavares, Paula Fonseca.   

Abstract

The Kallmann syndrome is characterised by the association of hypogonadotropic hypogonadism and hypo/anosmia. It represents a phenotypically and genotypically heterogeneous clinical entity, with six genes identified so far in the literature-KAL1, FGFR1, PROKR2, PROK2, CHD7 and FGF8. Mutations in the FGFR1 gene can be found in approximately 10% of the patients. The authors present the case of a female adolescent with hypogonadotropic hypogonadism and impaired olfactory acuity in the presence of hypoplasia of the nasal sulcus and agenesis of the olfactory bulbs. The molecular analysis of the fibroblast growth factor receptor 1 identified a heterozygous mutation c.1377_78insA (p.V460SfsX3) in exon 10 of FGFR1 gene. This mutation has not yet been reported in the literature. A theoretical review of clinical features and therapeutic approach of this syndrome is also presented.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22751423      PMCID: PMC4543024          DOI: 10.1136/bcr-12-2011-5380

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group.

Authors:  Carolyn A Bondy
Journal:  J Clin Endocrinol Metab       Date:  2006-10-17       Impact factor: 5.958

2.  Isolated gonadotropic deficiency with and without anosmia: a developmental defect or a neuroendocrine regulation abnormality of the gonadotropic axis.

Authors:  Nicolas de Roux
Journal:  Horm Res       Date:  2005

Review 3.  Reversible Kallmann syndrome: report of the first case with a KAL1 mutation and literature review.

Authors:  Rogerio Silicani Ribeiro; Teresa Cristina Vieira; Julio Abucham
Journal:  Eur J Endocrinol       Date:  2007-03       Impact factor: 6.664

4.  Kallmann syndrome.

Authors:  Catherine Dodé; Jean-Pierre Hardelin
Journal:  Eur J Hum Genet       Date:  2008-11-05       Impact factor: 4.246

Review 5.  The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al.

Authors:  J-P Hardelin; C Dodé
Journal:  Sex Dev       Date:  2008-11-05       Impact factor: 1.824

6.  Homozygous mutation in the prokineticin-receptor2 gene (Val274Asp) presenting as reversible Kallmann syndrome and persistent oligozoospermia: case report.

Authors:  Antonio Agostino Sinisi; Roberta Asci; Giuseppe Bellastella; Luigi Maione; Dario Esposito; Andrea Elefante; Annamaria De Bellis; Antonio Bellastella; Achille Iolascon
Journal:  Hum Reprod       Date:  2008-07-01       Impact factor: 6.918

7.  Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.

Authors:  Hyung-Goo Kim; Ingo Kurth; Fei Lan; Irene Meliciani; Wolfgang Wenzel; Soo Hyun Eom; Gil Bu Kang; Georg Rosenberger; Mustafa Tekin; Metin Ozata; David P Bick; Richard J Sherins; Steven L Walker; Yang Shi; James F Gusella; Lawrence C Layman
Journal:  Am J Hum Genet       Date:  2008-10-02       Impact factor: 11.025

Review 8.  Molecular pathogenesis of Kallmann's syndrome.

Authors:  Steven Mark Cadman; Soo-Hyun Kim; Youli Hu; David González-Martínez; Pierre-Marc Bouloux
Journal:  Horm Res       Date:  2006-12-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.